TrialJectory Blog
Myelofibrosis News
Latest News in MF Cancer Research Myelofibrosis (MF) is [...]
TrialJectory 2020 Review: A Big Step Towards Cancer Patient Empowerment
2020 has been a difficult year for all of us. [...]
Health Decisions, OncoBay Clinical, and TrialJectory Partner to Provide Specialized Clinical Development Services in Women’s Oncology
Durham, N.C., and Tampa, Fla., December 1, 2020 – Health [...]
TIME Selects TrialJectory’s AI-Powered, Clinical Trial-Matching Platform for ‘100 Best Inventions of 2020’ List
Annual List Highlights Groundbreaking Inventions that Change How We Live [...]
Dr. Len on Cancer Care and Research in a COVID World
https://youtu.be/miZEodmB5O4 Dr. Leonard Lichtenfeld is a board-certified medical [...]
Welcoming former Deputy Chief Medical Officer for American Cancer Society, Dr. J. Leonard Lichtenfeld to Our Advisory Board
“Dr. Len”, as He is Well Known in the Oncology [...]
Don’t Let Big Data Scare You Away from Cancer Treatment Options
Author, Cate North: As a breast cancer survivor since 2000 [...]
Why Clinical Trials Are Important – Dr. Dana RathKopf, M.D. Memorial Sloan Kettering Cancer Center
https://youtu.be/lXIBhKEmnkk Interviewer: Joining us now is Dr. Dana Rathkopf, [...]
Managing Sleep and Fatigue During Cancer Treatment with Light – A Talk by Dr. Ancoli-Israel, Ph.D.
https://youtu.be/Juqonpeneig Dr. Sonia Ancoli-Israel Ph.D. is Professor Emeritus [...]
Clinical Trial Experience Interview: Hedva Gonen, Melanoma Cancer Survivor
We are interviewing members of our community about their experience [...]